Published in Heart Rhythm on April 30, 2007
Totally Endoscopic Ablation of Atrial Fibrillation (TEA) | NCT00940056
Effect of Balloon Cryoablation on Left Atrial Function (CRYO-LA) | NCT00821015
Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol (2010) 3.18
Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol (2013) 2.58
Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57
Repolarization alternans reveals vulnerability to human atrial fibrillation. Circulation (2011) 2.14
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Acute exposure to air pollution triggers atrial fibrillation. J Am Coll Cardiol (2013) 1.90
One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace (2008) 1.89
Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg (2011) 1.87
Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm (2009) 1.82
The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ Arrhythm Electrophysiol (2011) 1.79
The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg (2011) 1.73
Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. J Am Coll Cardiol (2008) 1.71
A minimally invasive Cox maze IV procedure is as effective as sternotomy while decreasing major morbidity and hospital stay. J Thorac Cardiovasc Surg (2014) 1.61
Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation. J Am Coll Cardiol (2012) 1.54
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol (2010) 1.52
Outcome of pulmonary vein isolation ablation for paroxysmal atrial fibrillation: predictive role of left atrial mechanical dyssynchrony by speckle tracking echocardiography. J Interv Card Electrophysiol (2013) 1.41
Mitral isthmus ablation with and without temporary spot occlusion of the coronary sinus: a randomized clinical comparison of acute outcomes. J Cardiovasc Electrophysiol (2012) 1.40
Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation. J Cardiovasc Electrophysiol (2008) 1.38
Minimally invasive thoracoscopic hybrid treatment of lone atrial fibrillation: early results of monopolar versus bipolar radiofrequency source. Interact Cardiovasc Thorac Surg (2012) 1.34
Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 1.33
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J (2010) 1.25
Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol (2010) 1.18
MRI of the left atrium: predicting clinical outcomes in patients with atrial fibrillation. Expert Rev Cardiovasc Ther (2011) 1.17
Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue. PLoS One (2011) 1.17
Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med (2009) 1.17
The impact of CHADS2 score on late stroke after the Cox maze procedure. J Thorac Cardiovasc Surg (2012) 1.16
Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease. Ann Thorac Surg (2012) 1.13
Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessels (2012) 1.13
Atrial-selective sodium channel block for the treatment of atrial fibrillation. Expert Opin Emerg Drugs (2009) 1.12
Identification and acute targeting of gaps in atrial ablation lesion sets using a real-time magnetic resonance imaging system. Circ Arrhythm Electrophysiol (2012) 1.10
Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 1.09
Magnetic resonance image intensity ratio, a normalized measure to enable interpatient comparability of left atrial fibrosis. Heart Rhythm (2013) 1.08
Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol (2008) 1.05
Ablation for atrial fibrillation during mitral valve surgery: 1-year results through continuous subcutaneous monitoring. Interact Cardiovasc Thorac Surg (2012) 1.05
Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg (2012) 1.04
Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol (2011) 1.04
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. J Electrocardiol (2009) 1.04
A novel highly articulated robotic surgical system for epicardial ablation. Conf Proc IEEE Eng Med Biol Soc (2008) 1.03
Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol (2011) 1.03
Cryoballoon ablation for atrial fibrillation. Indian Pacing Electrophysiol J (2012) 1.01
Chronic performance of a novel radiofrequency ablation device on the beating heart: Limitations of conduction delay to assess transmurality. J Thorac Cardiovasc Surg (2012) 1.01
Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol (2009) 1.01
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation (2011) 0.97
Quantitative modeling of the accuracy in registering preoperative patient-specific anatomic models into left atrial cardiac ablation procedures. Med Phys (2014) 0.97
Trends in atrial fibrillation ablation: have we maximized the current paradigms? J Interv Card Electrophysiol (2012) 0.97
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc (2009) 0.93
Update on atrial fibrillation catheter ablation technologies and techniques. Nat Rev Cardiol (2013) 0.93
The hybrid approach for the surgical treatment of lone atrial fibrillation: one-year results employing a monopolar radiofrequency source. J Cardiothorac Surg (2012) 0.93
Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm (2010) 0.92
Early temporal and spatial regularization of persistent atrial fibrillation predicts termination and arrhythmia-free outcome. Heart Rhythm (2011) 0.91
Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol (2009) 0.90
Surgery for atrial fibrillation. Nat Rev Cardiol (2009) 0.90
A novel double cryoballoon strategy in persistent atrial fibrillation: a pilot study. Clin Res Cardiol (2012) 0.90
Comparison of contrast enhanced 64-slice computed tomography and transesophageal echocardiography in detection of left atrial thrombus in patients with atrial fibrillation. J Interv Card Electrophysiol (2008) 0.90
Effectiveness of Surgical Ablation in Patients With Atrial Fibrillation and Aortic Valve Disease. Ann Thorac Surg (2015) 0.89
Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2009) 0.89
Diagnostic performance of 320-slice multidetector computed tomography coronary angiography in patients after coronary artery bypass grafting. Eur Radiol (2011) 0.89
Left atrial appendage: morphology and function in patients with paroxysmal and persistent atrial fibrillation. Int J Cardiovasc Imaging (2012) 0.88
Alternative energy sources for surgical treatment of atrial fibrillation in patients undergoing mitral valve surgery: microwave ablation vs cryoablation. J Korean Med Sci (2010) 0.88
The surgical treatment of atrial fibrillation. Heart Rhythm (2009) 0.88
The surgical treatment of atrial fibrillation. Surg Clin North Am (2009) 0.88
Minimally invasive surgical therapies for atrial fibrillation. ISRN Cardiol (2012) 0.87
The effects of standard electrical PV isolation vs. "pace and ablate" on ATP-provoked PV reconnections. J Interv Card Electrophysiol (2014) 0.87
Ion channel trafficking: a new therapeutic horizon for atrial fibrillation. Heart Rhythm (2010) 0.86
Prediction of left atrial thrombi in patients with atrial tachyarrhythmias during warfarin administration: retrospective study in Hyogo College of Medicine. Heart Vessels (2015) 0.86
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. Ann N Y Acad Sci (2010) 0.86
Atrial Fibrillation Ablation without Interruption of Anticoagulation. Cardiol Res Pract (2011) 0.85
Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success. J Am Heart Assoc (2015) 0.85
Exchanging Catheters Over a Single Transseptal Sheath During Left Atrial Ablation is Associated with a Higher Risk for Silent Cerebral Events. Indian Pacing Electrophysiol J (2014) 0.85
Catheter ablation for atrial fibrillation. BMJ (2008) 0.85
Characteristics and Outcomes of Atrial Tachycardia Originating from the Sinus Venosus during Catheter Ablation of Atrial Fibrillation. Korean Circ J (2013) 0.85
Three-dimensional computed tomography overlay for pulmonary vein antrum isolation: Follow-up and clinical outcomes. Neth Heart J (2012) 0.85
Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. J Am Heart Assoc (2015) 0.85
Remote robotic catheter ablation for atrial fibrillation: how fast is it learned and what benefits can be earned? J Interv Card Electrophysiol (2010) 0.84
Cryoablation of atrial fibrillation. J Interv Card Electrophysiol (2011) 0.84
Noninvasive real-time mapping of an incomplete pulmonary vein isolation using electrocardiographic imaging. Heart Rhythm (2009) 0.84
Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome. J Interv Card Electrophysiol (2010) 0.84
Present concepts in management of atrial fibrillation: From drug therapy to ablation. World J Cardiol (2009) 0.84
Adenosine triphosphate-induced atrial fibrillation: the clinical significance and relevance to spontaneous atrial fibrillation. J Interv Card Electrophysiol (2013) 0.84
Surgical Ablation of Atrial Fibrillation Using Energy Sources. Braz J Cardiovasc Surg (2015) 0.83
Knowledge, attitude, and behavior in patients with atrial fibrillation undergoing radiofrequency catheter ablation. J Interv Card Electrophysiol (2010) 0.83
Challenges in the classification of atrial fibrillation. Nat Rev Cardiol (2010) 0.83
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram. PLoS One (2013) 0.83
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 0.83
Importance of atrial surface area and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. J Thorac Cardiovasc Surg (2012) 0.83
Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. Am J Cardiol (2012) 0.82
Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. Int J Cardiol (2014) 0.82
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation. Europace (2012) 0.82
Surveillance of AF recurrence post-surgical AF ablation using implantable cardiac monitor. J Interv Card Electrophysiol (2011) 0.81
[Nightmares in atrial fibrillation ablation--identification, management, and prevention of complications in radiofrequency ablation of atrial fibrillation]. Herzschrittmacherther Elektrophysiol (2007) 0.81
Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation. Neth Heart J (2012) 0.81
Omega-3 polyunsaturated Fatty Acid supplementation reduced atrial fibrillation recurrence after pulmonary vein antrum isolation. Indian Pacing Electrophysiol J (2009) 0.81
Conventional pulmonary vein isolation compared with the "box isolation" method: a randomized clinical trial. J Interv Card Electrophysiol (2011) 0.80
Catheter ablation of atrial fibrillation guided by a 3D electroanatomical mapping system: a 2-year follow-up study from the Italian Registry On NavX Atrial Fibrillation ablation procedures (IRON-AF). J Interv Card Electrophysiol (2013) 0.80
Pulmonary vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation: A single centre and single operator experience in the Netherlands. Neth Heart J (2009) 0.80
Role of three-dimensional imaging integration in atrial fibrillation ablation. World J Cardiol (2010) 0.80
Nonpharmacologic management of atrial fibrillation: role of the pulmonary veins and posterior left atrium. Heart Rhythm (2009) 0.80
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med (2006) 7.40
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 6.58
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol (2013) 5.67
An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med (2010) 5.32
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA (2005) 4.60
A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med (2009) 4.54
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46
A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med (2015) 4.17
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12
Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg (2003) 4.03
Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation (2003) 3.99
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation (2002) 3.76
Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation (2010) 3.72